Need help finding what you are looking for?
Contact Us
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1229557
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1229557
HIV/AIDS Diagnostics Market (Product: Kits and Reagents and Instruments; and Test Type: Nucleic Acid Tests, Rapid Tests, ELISA, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
The report provides revenue of the global HIV/AIDS diagnostics market for the period 2017-2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global HIV/AIDS diagnostics market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the HIV/AIDS diagnostics market.
The report delves into the competitive landscape of the global HIV/AIDS diagnostics market. Key players operating in the global HIV/AIDS diagnostics market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global HIV/AIDS diagnostics market profiled in this report.
Product Code: TMRGL26582
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global HIV/AIDS Diagnostics Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Definition
- 4.1.2. Industry Evolution/Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global HIV/AIDS Diagnostics Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projection (US$ Mn)
- 4.4.2. Market Volume/Unit Shipments Projection
- 4.5. Porter's Five Forces Analysis
5. Key Insights
- 5.1. HIV Disease Epidemiology
- 5.2. Technological Advancements
- 5.3. Key Mergers & Acquisitions
- 5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)
6. Global HIV/AIDS Diagnostics Market Analysis and Forecast, by Product
- 6.1. Introduction & Definition
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. Kits and Reagents
- 6.3.2. Instruments
- 6.4. Market Attractiveness Analysis, by Product
7. Global HIV/AIDS Diagnostics Market Analysis and Forecast, by Test Type
- 7.1. Introduction & Definition
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by Test Type, 2017-2031
- 7.3.1. Nucleic Acid Tests
- 7.3.2. Rapid Tests (POC)
- 7.3.3. ELISA
- 7.3.4. Others
- 7.4. Market Attractiveness Analysis, by Test Type
8. Global HIV/AIDS Diagnostics Market Analysis and Forecast, by End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings/Developments
- 8.3. Market Value Forecast, by End-user, 2017-2031
- 8.3.1. Hospitals
- 8.3.2. Diagnostic Laboratories
- 8.3.3. Academic and Research Institutes
- 8.3.4. Others
- 8.4. Market Attractiveness Analysis, by End-user
9. Global HIV/AIDS Diagnostics Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region, 2017-2031
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, by Region
10. North America HIV/AIDS Diagnostics Market Analysis and Forecast
- 10.1. Introduction
- 10.1.1. Key Findings
- 10.2. Market Value Forecast, by Product, 2017-2031
- 10.2.1. Kits and Reagents
- 10.2.2. Instruments
- 10.3. Market Value Forecast, by Test Type, 2017-2031
- 10.3.1. Nucleic Acid Tests
- 10.3.2. Rapid Tests (POC)
- 10.3.3. ELISA
- 10.3.4. Others
- 10.4. Market Value Forecast, by End-user, 2017-2031
- 10.4.1. Hospitals
- 10.4.2. Diagnostic Laboratories
- 10.4.3. Academic and Research Institutes
- 10.4.4. Others
- 10.5. Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Product
- 10.6.2. By Test Type
- 10.6.3. By End-user
- 10.6.4. By Country
11. Europe HIV/AIDS Diagnostics Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.2. Market Value Forecast, by Product, 2017-2031
- 11.2.1. Kits and Reagents
- 11.2.2. Instruments
- 11.3. Market Value Forecast, by Test Type, 2017-2031
- 11.3.1. Nucleic Acid Tests
- 11.3.2. Rapid Tests (POC)
- 11.3.3. ELISA
- 11.3.4. Others
- 11.4. Market Value Forecast, by End-user, 2017-2031
- 11.4.1. Hospitals
- 11.4.2. Diagnostic Laboratories
- 11.4.3. Academic and Research Institutes
- 11.4.4. Others
- 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Italy
- 11.5.5. Spain
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Product
- 11.6.2. By Test Type
- 11.6.3. By End-user
- 11.6.4. By Country/Sub-region
12. Asia Pacific HIV/AIDS Diagnostics Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast, by Product, 2017-2031
- 12.2.1. Kits and Reagents
- 12.2.2. Instruments
- 12.3. Market Value Forecast, by Test Type, 2017-2031
- 12.3.1. Nucleic Acid Tests
- 12.3.2. Rapid Tests (POC)
- 12.3.3. ELISA
- 12.3.4. Others
- 12.4. Market Value Forecast, by End-user, 2017-2031
- 12.4.1. Hospitals
- 12.4.2. Diagnostic Laboratories
- 12.4.3. Academic and Research Institutes
- 12.4.4. Others
- 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Product
- 12.6.2. By Test Type
- 12.6.3. By End-user
- 12.6.4. By Country/Sub-region
13. Latin America HIV/AIDS Diagnostics Market Analysis and Forecast
- 13.1. Introduction
- 13.1.1. Key Findings
- 13.2. Market Value Forecast, by Product, 2017-2031
- 13.2.1. Kits and Reagents
- 13.2.2. Instruments
- 13.3. Market Value Forecast, by Test Type, 2017-2031
- 13.3.1. Nucleic Acid Tests
- 13.3.2. Rapid Tests (POC)
- 13.3.3. ELISA
- 13.3.4. Others
- 13.4. Market Value Forecast, by End-user, 2017-2031
- 13.4.1. Hospitals
- 13.4.2. Diagnostic Laboratories
- 13.4.3. Academic and Research Institutes
- 13.4.4. Others
- 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Product
- 13.6.2. By Test Type
- 13.6.3. By End-user
- 13.6.4. By Country/Sub-region
14. Middle East & Africa HIV/AIDS Diagnostics Market Analysis and Forecast
- 14.1. Introduction
- 14.1.1. Key Findings
- 14.2. Market Value Forecast, by Product, 2017-2031
- 14.2.1. Kits and Reagents
- 14.2.2. Instruments
- 14.3. Market Value Forecast, by Test Type, 2017-2031
- 14.3.1. Nucleic Acid Tests
- 14.3.2. Rapid Tests (POC)
- 14.3.3. ELISA
- 14.3.4. Others
- 14.4. Market Value Forecast, by End-user, 2017-2031
- 14.4.1. Hospitals
- 14.4.2. Diagnostic Laboratories
- 14.4.3. Academic and Research Institutes
- 14.4.4. Others
- 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Product
- 14.6.2. By Test Type
- 14.6.3. By End-user
- 14.6.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Market Share Analysis, by Company (2021)
- 15.3. Company Profiles
- 15.3.1. Hologic, Inc
- 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.1.2. Product Portfolio
- 15.3.1.3. Financial Overview
- 15.3.1.4. SWOT Analysis
- 15.3.1.5. Strategic Overview
- 15.3.2. Abbott
- 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.2.2. Product Portfolio
- 15.3.2.3. Financial Overview
- 15.3.2.4. SWOT Analysis
- 15.3.2.5. Strategic Overview
- 15.3.3. Bio-Rad Laboratories, Inc.
- 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.3.2. Product Portfolio
- 15.3.3.3. Financial Overview
- 15.3.3.4. SWOT Analysis
- 15.3.3.5. Strategic Overview
- 15.3.4. F. Hoffmann-La Roche Ltd.
- 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.4.2. Product Portfolio
- 15.3.4.3. Financial Overview
- 15.3.4.4. SWOT Analysis
- 15.3.4.5. Strategic Overview
- 15.3.5. OraSure Technologies, Inc.
- 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.5.2. Product Portfolio
- 15.3.5.3. Financial Overview
- 15.3.5.4. SWOT Analysis
- 15.3.6. Siemens Healthcare GmbH
- 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.6.2. Product Portfolio
- 15.3.6.3. Financial Overview
- 15.3.6.4. SWOT Analysis
- 15.3.7. Chembio Diagnostics, Inc.
- 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.7.2. Product Portfolio
- 15.3.7.3. Financial Overview
- 15.3.7.4. SWOT Analysis
- 15.3.8. Danaher Corporation
- 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.8.2. Product Portfolio
- 15.3.8.3. Financial Overview
- 15.3.8.4. SWOT Analysis
- 15.3.9. Becton, Dickinson and Company
- 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.9.2. Product Portfolio
- 15.3.9.3. Financial Overview
- 15.3.9.4. SWOT Analysis
- 15.3.1. Hologic, Inc
Product Code: TMRGL26582
List of Tables
- Table 01: Global HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2031
- Table 02: Global HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
- Table 03: Global HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
- Table 04: Global HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2031
- Table 05: North America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2031
- Table 06: North America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2031
- Table 07: North America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
- Table 08: North America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
- Table 09: Europe HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
- Table 10: Europe HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2031
- Table 11: Europe HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
- Table 12: Europe HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
- Table 13: Asia Pacific HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
- Table 14: Asia Pacific HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2031
- Table 15: Asia Pacific HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
- Table 16: Asia Pacific HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
- Table 17: Latin America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
- Table 18: Latin America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2031
- Table 19: Latin America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
- Table 20: Latin America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
- Table 21: Middle East & Africa HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
- Table 22: Middle East & Africa HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2031
- Table 23: Middle East & Africa HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
- Table 24: Middle East & Africa HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
- Figure 01: Market Share, By Product
- Figure 02: Market Share, By Test Type
- Figure 03: Market Share, By End-user
- Figure 04: Market Share, By Region
- Figure 05: Figure 05: Global HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
- Figure 06: Figure 06: Global HIV/AIDS Diagnostics Market Value Share, by Product (2021)
- Figure 07: Figure 07: Global HIV/AIDS Diagnostics Market Value Share, by End-user (2021)
- Figure 08: Global HIV/AIDS Diagnostics Market Value Share, by Test Type (2021)
- Figure 09: Global HIV/AIDS Diagnostics Market Value Share, by Region (2021)
- Figure 10: Global HIV/AIDS Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
- Figure 11: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn), by Kits and Reagents, 2017-2031
- Figure 12: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn), by Instruments, 2017-2031
- Figure 13: Global HIV/AIDS Diagnostics Market Attractiveness, by Product, 2022-2031
- Figure 14: Global HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
- Figure 15: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn), by Nucleic Acid Tests, 2017-2031
- Figure 16: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn), by Rapid Tests (POC), 2017-2031
- Figure 17: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn), by ELISA, 2017-2031
- Figure 18: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn), by Others, 2017-2031
- Figure 19: Global HIV/AIDS Diagnostics Market Attractiveness, by Test Type, 2022-2031
- Figure 20: Global HIV/AIDS Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
- Figure 21: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn), by Hospitals, 2017-2031
- Figure 22: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn), by Diagnostic Laboratories, 2017-2031
- Figure 23: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn), by Academic and Research Institutes, 2017-2031
- Figure 24: Global HIV/AIDS Diagnostics Market Revenue (US$ Mn), by Others, 2017-2031
- Figure 25: Global HIV/AIDS Diagnostics Market Attractiveness, by End-user, 2022-2031
- Figure 26: Global HIV/AIDS Diagnostics Market Value Share Analysis, by Region, 2021 and 2031
- Figure 27: Global HIV/AIDS Diagnostics Market Attractiveness, by Region, 2022-2031
- Figure 28: North America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
- Figure 29: North America HIV/AIDS Diagnostics Market Value Share (%), by Country, 2021 and 2031
- Figure 30: North America HIV/AIDS Diagnostics Market Attractiveness, by Country, 2022-2031
- Figure 31: North America HIV/AIDS Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
- Figure 32: North America HIV/AIDS Diagnostics Market Attractiveness, by Product, 2022-2031
- Figure 33: North America HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
- Figure 34: North America HIV/AIDS Diagnostics Market Attractiveness, by Test Type, 2022-2031
- Figure 35: North America HIV/AIDS Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
- Figure 36: North America HIV/AIDS Diagnostics Market Attractiveness, by End-user, 2022-2031
- Figure 37: Europe HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
- Figure 38: Europe HIV/AIDS Diagnostics Market Value Share (%), by Country/Sub-region, 2021 and 2031
- Figure 39: Europe HIV/AIDS Diagnostics Market Attractiveness, by Country/Sub-region, 2022-2031
- Figure 40: Europe HIV/AIDS Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
- Figure 41: Europe HIV/AIDS Diagnostics Market Attractiveness, by Product, 2022-2031
- Figure 42: Europe HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
- Figure 43: Europe HIV/AIDS Diagnostics Market Attractiveness, by Test Type, 2022-2031
- Figure 44: Europe HIV/AIDS Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
- Figure 45: Europe HIV/AIDS Diagnostics Market Attractiveness, by End-user, 2022-2031
- Figure 46: Asia Pacific HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
- Figure 47: Asia Pacific HIV/AIDS Diagnostics Market Value Share (%), by Country/Sub-region, 2021 and 2031
- Figure 48: Asia Pacific HIV/AIDS Diagnostics Market Attractiveness, by Country/Sub-region, 2022-2031
- Figure 49: Asia Pacific HIV/AIDS Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
- Figure 50: Asia Pacific HIV/AIDS Diagnostics Market Attractiveness, by Product, 2022-2031
- Figure 51: Asia Pacific HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
- Figure 52: Asia Pacific HIV/AIDS Diagnostics Market Attractiveness, by Test Type, 2022-2031
- Figure 53: Asia Pacific HIV/AIDS Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
- Figure 54: Asia Pacific HIV/AIDS Diagnostics Market Attractiveness, by End-user, 2022-2031
- Figure 55: Latin America HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
- Figure 56: Latin America HIV/AIDS Diagnostics Market Value Share (%), by Country/Sub-region, 2021 and 2031
- Figure 57: Latin America HIV/AIDS Diagnostics Market Attractiveness, by Country/Sub-region, 2022-2031
- Figure 58: Latin America HIV/AIDS Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
- Figure 59: Latin America HIV/AIDS Diagnostics Market Attractiveness, by Product, 2022-2031
- Figure 60: Latin America HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
- Figure 61: Latin America HIV/AIDS Diagnostics Market Attractiveness, by Test Type, 2022-2031
- Figure 62: Latin America HIV/AIDS Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
- Figure 63: Latin America HIV/AIDS Diagnostics Market Attractiveness, by End-user, 2022-2031
- Figure 64: Middle East & Africa HIV/AIDS Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
- Figure 65: Middle East & Africa HIV/AIDS Diagnostics Market Value Share (%), by Country/Sub-region, 2021 and 2031
- Figure 66: Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness, by Country/Sub-region, 2022-2031
- Figure 67: Middle East & Africa HIV/AIDS Diagnostics Market Value Share Analysis, by Product, 2021 and 2031
- Figure 68: Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness, by Product, 2022-2031
- Figure 69: Middle East & Africa HIV/AIDS Diagnostics Market Value Share Analysis, by Test Type, 2021 and 2031
- Figure 70: Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness, by Test Type, 2022-2031
- Figure 71: Middle East & Africa HIV/AIDS Diagnostics Market Value Share Analysis, by End-user, 2021 and 2031
- Figure 72: Middle East & Africa HIV/AIDS Diagnostics Market Attractiveness, by End-user, 2022-2031
- Figure 73: Global HIV/AIDS Diagnostics Market Share Analysis, by Company, 2021
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.